Related Experiment Video
Updated: Oct 27, 2025

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Silencing the G-protein coupled receptor 3-salt inducible kinase 2 pathway promotes human β cell proliferation
Caterina Iorio1, Jillian L Rourke1,2, Lisa Wells1
1Sunnybrook Research Institute, Toronto, Canada.
Abstract:
Loss of pancreatic β cells is the hallmark of type 1 diabetes, for which provision of insulin is the standard of care. While regenerative and stem cell therapies hold the promise of generating single-source or host-matched tissue to obviate immune-mediated complications, these will still require surgical intervention and immunosuppression. Here we report the development of a high-throughput RNAi screening approach to identify upstream pathways that regulate adult human β cell quiescence and demonstrate in a screen of the GPCRome that silencing G-protein coupled receptor 3 (GPR3) leads to human pancreatic β cell proliferation. Loss of GPR3 leads to activation of Salt Inducible Kinase 2 (SIK2), which is necessary and sufficient to drive cell cycle entry, increase β cell mass, and enhance insulin secretion in mice. Taken together, our data show that targeting the GPR3-SIK2 pathway is a potential strategy to stimulate the regeneration of β cells.
Insights
Researchers identified a new pathway to regenerate pancreatic beta cells, crucial for treating type 1 diabetes. Silencing G-protein coupled receptor 3 (GPR3) promotes beta cell proliferation and function.
Area of Science:
- Endocrinology and Metabolism
- Cell Biology
- Diabetes Research
Background:
- Type 1 diabetes is characterized by the loss of pancreatic beta cells, necessitating insulin therapy.
- Current regenerative therapies face challenges including immune rejection and the need for immunosuppression.
Purpose of the Study:
- To identify novel pathways regulating adult human beta cell quiescence.
- To explore therapeutic targets for stimulating beta cell regeneration.
Main Methods:
- Development of a high-throughput RNA interference (RNAi) screen targeting the GPCRome.
- Investigation of the G-protein coupled receptor 3 (GPR3) and its downstream effects.
Main Results:
- Silencing GPR3 induced proliferation of human pancreatic beta cells.
- GPR3 loss activated Salt Inducible Kinase 2 (SIK2), driving cell cycle entry and increasing beta cell mass.
- SIK2 activation enhanced insulin secretion in mouse models.
Conclusions:
- The GPR3-SIK2 pathway is a critical regulator of beta cell mass and function.
- Targeting this pathway offers a potential strategy for stimulating beta cell regeneration in diabetes.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Amplifying Signals via Enzymatic Cascade
Cell Specific Gene Expression

